急性缺血性卒中血管再通治疗不良预后的预测研究进展

doi:10.3969/j.issn.1673-5765.2019.06.012

摘要/Abstract

摘要：

急性缺血性卒中（acute ischemic stroke，AIS）治疗的关键在于早期血管再通，挽救缺血半暗带。然而早期再通的效果存在个体差异，难以早期预测，且增加了脑梗死后出血转化的风险。为了能够早期判断AIS患者早期血管再通的预后及出血转化风险，多年来国内外学者一直致力于这方面预测模型的研发及应用，相关评分预测模型也层出不穷。本文对近年一些相关预测模型的研究进展进行回顾，以期待对未来的临床工作及科学研究提供帮助和启示。

文章导读： 本文回顾总结了近年国内外研发的急性缺血性卒中血管再通治疗预后预测模型的研究进展。

关键词: 缺血性卒中; 静脉溶栓; 血管内治疗; 预后; 出血转化; 评分

Abstract:

The key of acute ischemic stroke (AIS) treatment is early vascular recanalization to save ischemic penumbra. However, the effect of early recanalization has individual differences, which is difficult to predict early, and the risk of hemorrhagic transformation often increases after recanalization. In order to predict the prognosis and risk of hemorrhagic transformation early in AIS patients, scholars at home and abroad have been devoting themselves to the development and application of prediction models in this field for many years, and related scoring prediction models have emerged in endlessly. This paper reviewed the progress of some prediction models in recent years in order to provide help and inspiration for future clinical work and scientific research.

Key words: Ischemic stroke; Intravenous thrombolysis; Endovascular treatment; Prognosis;Hemorrhagic transformation; Score

郑国将，卓子良，聂志余. 急性缺血性卒中血管再通治疗不良预后的预测研究进展[J]. 中国卒中杂志, 2019, 14(06): 586-593.

ZHENG Guo-Jiang, ZHUO Zi-Liang, NIE Zhi-Yu. Advances in Predicting Adverse Prognosis after Vascular Recanalization in Acute Ischemic Stroke[J]. Chinese Journal of Stroke, 2019, 14(06): 586-593.

参考文献

[1] WANG W，JIANG B，SUN H，et al. Prevalence，

incidence and mortality of stroke in China：results

from a nationwide population-based survey of 480，

687 adults[J]. Circulation，2017，135（8）：759-771.

[2] BENJAMIN E J，VIRANI S S，CALLAWAY C W，

et al. Heart disease and stroke statistics-2018 update：

a report from the American Heart Association[J/OL].

Circulation，2018，137（12）：e67-e492. https：//doi.

org/10.1161/CIR.0000000000000558.

[3] 陈伟伟，高润霖，刘力生，等. 中国心血管病报告2017

概要[J]. 中国循环杂志，2018，33（1）：1-8.

[4] VAN SWIETEN J C，KOUDSTAAL P J，VISSER M

C，et al. Interobserver agreement for the assessment

of handicap in stroke patients[J]. Stroke，1988，19

（5）：604-607.

[5] QUINN T J，PETER L，STOTT D J. Barthel index

for stroke trials development，properties，and

application[J]. Stroke，2011，42（4）：1146-1151.

[6] KAY R，WONG K S，PEREZ G，et al.

Dichotomizing stroke outcomes based on selfreported

dependency[J]. Neurology，1997，49（6）：

1694-1696.

[7] SULTER G，STEEN C，DE KEYSER J. Use of the

Barthel index and modified Rankin scale in acute

stroke trials[J]. Stroke，1999，30（8）：1538-1541.

[8] UYTTENBOOGAART M，STEWART R E，

VROOMEN P C，et al. Optimizing cutoff scores for

the Barthel index and the modified Rankin scale for

defining outcome in acute stroke trials[J]. Stroke，

2005，36（9）：1984-1987.

[9] The National Institute of Neurological Disorders

and Stroke rt-PA Stroke Study Group. Tissue

plasminogen activator for acute ischemic stroke[J].

N Engl J Med，1995，333（24）：1581-1588.

[10] HACKE W，KASTE M，FIESCHI C，et al.

Randomised double-blind placebo-controlled

trial of thrombolytic therapy with intravenous

alteplase in acute ischaemic stroke（ECASS Ⅱ）.

Second European-Australasian Acute Stroke Study

Investigators[J]. Lancet，1998，352（9136）：1245-

1251.

[11] WAHLGREN N，AHMED N，DÁVALOS A，et

al. Thrombolysis with alteplase for acute ischaemic

stroke in the Safe Implementation of Thrombolysis

in Stroke Monitoring Study（SITS-MOST）：an

observational study[J]. Lancet，2007，369（9558）：

275-282.

[12] ADAMS H P，DAVIS P H，LEIRA E C，et al.

Baseline NIH Stroke Scale score strongly predicts

outcome after stroke A report of the Trial of Org

10 172 in Acute Stroke Treatment（TOAST）[J].

Neurology，1999，53（1）：126-131.

[13] BANG O Y，PARK H Y，YOON J H，et al.

Predicting the long-term outcome after subacute

stroke within the middle cerebral artery territory[J].

J Clin Neurol，2005，1（2）：148-158.

[14] AOKI J，KIMURA K，KOGA M，et al. NIHSS-time

score easily predicts outcomes in rt-PA patients：the

SAMURAI rt-PA registry[J]. J Neurol Sci，2013，327

（1-2）：6-11.

[15] TODO K，SAKAI N，KONO T，et al. National

institutes of health stroke scale-time score predicts

outcome after endovascular therapy in acute

ischemic stroke：a retrospective single-center

study[J]. J Stroke Cerebrovasc Dis，2016，25（5）：

1187-1191.

[16] BARBER P A，DEMCHUK A M，ZHANG

J，et al. Validity and reliability of a quantitative

computed tomography score in predicting outcome

of hyperacute stroke before thrombolytic therapy.

ASPECTS Study Group. Alberta Stroke Programme

Early CT Score[J]. Lancet，2000，355（9216）：1670-

1674.

[17] MACCALLUM C，CHURILOV L，MITCHELL P，

et al. Low Alberta Stroke Program Early CT Score

（ASPECTS）associated with malignant middle

cerebral artery infarction[J]. Cerebrovasc Dis，2014，

38（1）：39-45.

[18] BUTCHER K，PARSONS M，ALLPORT L，et

al. Rapid assessment of perfusion-diffusion

mismatch[J]. Stroke，2008，39（1）：75-81.

[19] PADRONI M，BERNARDONI A，TAMBORINO

C，et al. Cerebral blood volume ASPECTS is the

best predictor of clinical outcome in acute ischemic

stroke：a retrospective，combined semi-quantitative

and quantitative assessment[J/OL]. PLoS One，2016，

11（1）：e0147910. https：//doi.org/10.1371/journal.

pone.0147910.

[20] DESILLES J P，CONSOLI A，REDJEM H，et

al. Successful reperfusion with mechanical

thrombectomy is associated with reduced disability

and mortality in patients with Pretreatment

diffusion-weighted Imaging-Alberta stroke program

early computed tomography score ≤6[J]. Stroke，2017，48（4）：963-969.

[21] PUETZ V，SYLAJA P N，COUTTS S B，et al.

Extent of hypoattenuation on CT angiography source

images predicts functional outcome in patients with

basilar artery occlusion[J]. Stroke，2008，39（9）：

2485-2490.

[22] PUETZ V，KHOMENKO A，HILL M D，et al.

Extent of hypoattenuation on CT angiography source

images in basilar artery occlusion：prognostic value

in the Basilar Artery International Cooperation

Study [J]. Stroke，2011，42（12）：3454-3459.

[23] KARAMESHEV A，ARNOLD M，SCHROTH G，

et al. Diffusion-weighted MRI helps predict outcome

in basilar artery occlusion patients treated with intraarterial

thrombolysis[J]. Cerebrovasc Dis，2011，32

（4）：393-400.

[24] MUNDIYANAPURATH S，MÖHLENBRUCH

M，RINGLEB P A，et al. Posterior circulation acute

stroke prognosis early computed tomography score

using hypointense vessels on susceptibility weighted

imaging independently predicts outcome in patients

with basilar artery occlusion[J/OL]. PLoS One，2015，

10（7）：e0132587. https：//doi.org/10.1371/journal.

pone.0132587.

[25] LOU M，SAFDAR A，MEHDIRATTA M，et al.

The HAT score a simple grading scale for predicting

hemorrhage after thrombolysis[J]. Neurology，2008，

71（18）：1417-1423.

[26] STRBIAN D，ENGELTER S，MICHEL P，et al.

Symptomatic intracranial hemorrhagem after stroke

thrombolysis：the SEDAN Score [J]. Ann Neurol，

2012，71（5）：634-641.

[27] NTAIOS G，FAOUZI M，FERRARI J，et al. An

integer-based score to predict functional outcome

in acute ischemic stroke：the ASTRAL score[J].

Neurology，2012，78（24）：1916-1922.

[28] STRBIAN D，MERETOJA A，AHLHELM F J，et

al. Predicting outcome of Ⅳ thrombolysis-treated

ischemic stroke patients：the DRAGON score[J].

Neurology，2012，78（6）：427-432.

[29] TURC G，AGUETTAZ P，PONCHELLEDEQUATRE

N，et al. External validation of the

MRI-DRAGON score：early prediction of stroke

outcome after intravenous thrombolysis[J/OL].

PLoS One，2014，9（6）：p. e99164. https：//doi.

org/10.1371/journal.pone.0099164.

[30] KENT D M，SELKER H P，RUTHAZER R，et al.

The stroke thrombolytic predictive instrument：a

predictive instrument for intravenous thrombolysis

in acute ischemic stroke[J]. Stroke，2006，37（12）：

2957-2962.

[31] UYTTENBOOGAART M，STEWART R

E，VROOMEN P C，et al. Utility of the strokethrombolytic

predictive instrument[J]. J Neurol

Neurosurg Psychiatry，2008，79（9）：1079-1081.

[32] MOLINA C A，ALEXANDROV A V，DEMCHUK

A M，et al. Improving the predictive accuracy of

recanalization on stroke outcome in patients treated

with tissue plasminogen activator[J]. Stroke，2004，

35（1）：151-156.

[33] PAN Y，JING J，ZHANG R，et al. Poor performance

of stroke prognostication using Age and National

Institutes of Health Stroke Scale-100 to Predict 3-and

12-month outcomes of ischemic stroke in China

National Stroke Registry[J]. J Stroke Cerebrovasc

Dis，2014，23（9）：2335-2340.

[34] ASUZU D，NYSTRÖM K，SCHINDLER J，et

al. TURN Score predicts 90-day outcome in acute

ischemic stroke patients after IV thrombolysis[J].

Neurocrit Care，2015，23（2）：172-178.

[35] ASUZU D，NYSTRÖM K，AMIN H，et al. TURN：

a simple predictor of symptomatic intracerebral

hemorrhage after IV thrombolysis[J]. Neurocrit Care，

2015，23（2）：166-171.

[36] GUSTAVO S，STAVROULA R，KAPRAL M K，et

al. The iScore predicts poor functional outcomes

early after hospitalization for an acute ischemic

stroke[J]. Stroke，2011，42（12）：3421-3428.

[37] ZHANG N，LIU G，ZHANG G，et al. External

validation of the iScore for predicting ischemic

stroke mortality in patients in China[J]. Stroke，2013，

44（7）：1924-1929.

[38] MENON B K，SAVER J L，PRABHAKARAN S，et

al. Risk score for intracranial hemorrhage in patients

with acute ischemic stroke treated with intravenous

tissue-type plasminogen activator[J]. Stroke，2012，

43（9）：2293-2299.

[39] MAZYA M，EGIDO J A，FORD G A，et al.

Predicting the risk of symptomatic intracerebral

hemorrhage in ischemic stroke treated with

intravenous alteplase：Safe Implementation

of Treatments in Stroke（SITS）symptomatic

intracerebral hemorrhage risk score[J]. Stroke，2012，

43（6）：1524-1531.

[40] CUCCHIARA B，TANNE D，LEVINE S R，et al.

A risk score to predict intracranial hemorrhage after

recombinant tissue plasminogen activator for acute

ischemic stroke[J]. J Stroke Cerebrovasc Dis，2008，

17（6）：331-333.

[41] WHITELEY W N，THOMPSON D，MURRAY G，

et al. Targeting recombinant tissue-type plasminogen

activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome：

an analysis of the third international stroke trial[J].

Stroke，2014，45（4）：1000-1006.

[42] LOKESKRAWEE T，MUENGTAWEEPONGSA S，

PATUMANOND J，et al. Prediction of symptomatic

intracranial hemorrhage after intravenous

thrombolysis in acute ischemic stroke：the

Symptomatic Intracranial Hemorrhage Score[J]. J

Stroke Cerebrovasc Dis，2017，26（11）：2622-2629.

[43] FLINT A C，CULLEN S P，FAIGELES B S，et al.

Predicting long-term outcome after endovascular

stroke treatment：the totaled health risks in vascular

events score[J]. AJNR Am J Neuroradiol，2010，31

（7）：1192-1196.

[44] FLINT A C，FAIGELES B S，CULLEN S P，et al.

THRIVE score predicts ischemic stroke outcomes

and thrombolytic hemorrhage risk in VISTA[J].

Stroke，2013，44（12）：3365-3369.

[45] HALLEVI H，BARRETO A D，LIEBESKIND

D S，et al. Identifying patients at high risk for

poor outcome after-intra arterial therapy for acute

ischemic stroke[J]. Stroke，2009，40（5）：1780-1785.

[46] SARRAJ A，ALBRIGHT K，BARRETO A D，et al.

Optimizing prediction scores for poor outcome after

intra-arterial therapy in anterior circulation acute

ischemic stroke[J]. Stroke，2013，44（12）：3324-

3330.

[47] LIGGINS J T P，YOO A J，MISHRA N K，et al. A

score based on age and DWI volume predicts poor

outcome following endovascular treatment for acute

ischemic stroke[J]. Int J Stroke，2015，10（5）：705-

709.

[48] RANGARAJU S，AGHAEBRAHIM A，STREIB

C，et al. Pittsburgh Response to Endovascular

therapy（PRE）score：optimizing patient selection

for endovascular therapy for large vessel occlusion

strokes[J]. J Neurointerv Surg，2015，7（11）：783-

788.